US-based medical equipment maker Medtronic has reportedly formally submitted its request to the European Commission to acquire Irish peer Covidien in a $3 billion acquisition.
Reports say the takeover will push Medtronic onto a more level playing field with global industry leader Johnson & Johnson. The deal will also lower Medtronic’s tax burden by relocating its tax domicile overseas.
Such mergers, known as inversion deals, have come under scrutiny by both US and EU authorities, however. But Medtronic said that the takeover is not an inversion deal and, instead, aims to refocus its medical technology strategy, according to reports.
The Commission set a deadline to decide on the deal for November 14, reports say.
Full content: Reuters
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Uruguayan Antitrust Scrutiny Puts Major Meatpacking Deal Between Marfrig and Minerva on Hold
May 19, 2024 by
CPI
Alaska Airlines Seeks Dismissal of Consumer Lawsuit Over $1.9 Billion Hawaiian Airlines Buy
May 19, 2024 by
CPI
Idaho Attorney General Orders Split of Kootenai Health and Syringa Hospital
May 19, 2024 by
CPI
Court Rejects T-Mobile’s Appeal Bid in Antitrust Case Over Sprint Merger
May 19, 2024 by
CPI
Google Requests Judge, Not Jury, to Decide on Antitrust Case
May 19, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Ecosystems
May 9, 2024 by
CPI
Mapping Antitrust onto Digital Ecosystems
May 9, 2024 by
CPI
Ecosystems and Competition Law: A Law and Political Economy Approach
May 9, 2024 by
CPI
Ecosystem Theories of Harm: What is Beyond the Buzzword?
May 9, 2024 by
CPI
Open Ecosystems: Benefits, Challenges, and Implications for Antitrust
May 9, 2024 by
CPI